Jean‐Pierre Devogelaer
Impact in
- Orthopedics and Sports Medicine top 0.1%
- Bone health and osteoporosis research
- Bone and Joint Diseases
- Rheumatology top 0.5%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Bone health and osteoporosis research 52
- Bone and Joint Diseases 23
- Rheumatology 35
- Osteoarthritis Treatment and Mechanisms 11
- Co-authors
- C Nagant de DeuxchaisnesD. ManicourtFrédéric HoussiauJacques Van SnickJo Van DammeJean‐Yves ReginsterDavid HoskingJose Adolfo Rodriguez-Portales
- Journals
- Calcified Tissue International (14 papers)Journal of Bone and Mineral Research (13 papers)Osteoporosis International (8 papers)Bone (7 papers)Obstetrical & Gynecological Survey (4 papers)
- Partner nations
- BelgiumUnited StatesSwitzerland
In The Last Decade
Jean‐Pierre Devogelaer
145 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Orthopedics and Sports Medicine 3.1k
- Rheumatology 1.5k
- Oncology 2.7k
- Nephrology 228
- Pathology and Forensic Medicine 577
Countries citing papers authored by Jean‐Pierre Devogelaer
This map shows the geographic impact of Jean‐Pierre Devogelaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Devogelaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Devogelaer more than expected).
Fields of papers citing papers by Jean‐Pierre Devogelaer
This network shows the impact of papers produced by Jean‐Pierre Devogelaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Devogelaer. The network helps show where Jean‐Pierre Devogelaer may publish in the future.
Co-authors
The 25 scholars most cited alongside Jean‐Pierre Devogelaer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2019 | 5 | |
| 3 | 2011 | 2 | |
| 4 | 2009 | 1 | |
| 5 | A single infusion of zoledronic acid 5 mg (ZOL) is significantly more effective than daily oral risedronate 5 mg (RIS) in increasing bone mineral density (BMD) of the lumbar spine (LS), hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis (GIO) | 2008 | 1 |
| 6 | 2008 | 1 | |
| 7 | Effect of a Single 5-mg Infusion of Zoledronic Acid on Bone Turnover Markers Versus Oral Risedronate (5 mg/day) Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis. | 2008 | 1 |
| 8 | 2007 | 67 | |
| 9 | Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate | 2007 | 1 |
| 10 | Zoledronic acid safety and efficacy over 5 years in post-menopausal osteoporosis | 2006 | 1 |
| 11 | Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia | 2004 | 3 |
| 12 | The effect of infliximab therapy on the prevention of new erosions in patients with early rheumatoid arthritis. | 2004 | 2 |
| 13 | Strontium ranelate reduces the risk of hip fracture in women with postmenopausal osteoporosis | 2002 | 15 |
| 14 | Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis. | 2002 | 2 |
| 15 | Evaluation de la substitution par corticostéroïdes et de ses répercussions osseuses dans la maladie d'Addison. | 2000 | 5 |
| 16 | Therapy and the 1990s - Osteoporosis | 1993 | 11 |
| 17 | A Study of the Accuracy of 3 Dpa, and One Dual-energy X-ray Bone Densitometers | 1990 | 3 |
| 18 | Effect of a Nasal Spray of Salmon-calcitonin in Normal Subjects and in Patients With Pagets-disease of Bone | 1986 | 3 |
| 19 | Effect of Glucocorticoids On Bone - a Radiologic and Absorptiometric Approach | 1982 | 1 |
| 20 | [Roentgenologic Evaluation of the Action of the Diphosphonate Ehdp and of Combined Therapy (ehdp and Calcitonin) in Pagets-disease of Bone] | 1980 | 11 |
About Jean‐Pierre Devogelaer
Jean‐Pierre Devogelaer is a scholar working on Orthopedics and Sports Medicine, Rheumatology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 147 papers that have together received 6.7k indexed citations. Recurring topics across this work include Bone health and treatments (58 papers), Bone health and osteoporosis research (52 papers), Bone and Joint Diseases (23 papers), Bone Metabolism and Diseases (21 papers), Osteoarthritis Treatment and Mechanisms (11 papers), Hip and Femur Fractures (10 papers), Genetic Syndromes and Imprinting (8 papers) and Medical Imaging and Pathology Studies (8 papers). The work is most often cited by research in Orthopedics and Sports Medicine (3.1k citations), Rheumatology (1.5k citations), Oncology (2.7k citations), Nephrology (228 citations) and Pathology and Forensic Medicine (577 citations). Jean‐Pierre Devogelaer has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include C Nagant de Deuxchaisnes, D. Manicourt, Frédéric Houssiau, Jacques Van Snick, Jo Van Damme, Jean‐Yves Reginster, David Hosking, Jose Adolfo Rodriguez-Portales, Robert W. Downs and Richard P. Tonino. Their work appears in journals such as Calcified Tissue International, Journal of Bone and Mineral Research, Osteoporosis International, Bone and Obstetrical & Gynecological Survey.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.